Cargando…

Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4‐IgG‐seropositive neuromyelitis optica spectrum disorder

INTRODUCTION: The aim was to characterize the optical coherence tomography (OCT) angiography measures in patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) and to evaluate their disease discrimination capacity. METHODS: Patients with MS (n = 83) and AQP4‐IgG‐ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chunxin, Xiao, Hui, Zhang, Xiayin, Zhao, Yipeng, Li, Rui, Zhong, Xiaonan, Wang, Yuge, Shu, Yaqing, Chang, Yanyu, Wang, Jingqi, Li, Caixia, Lin, Haotian, Qiu, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119797/ https://www.ncbi.nlm.nih.gov/pubmed/33784027 http://dx.doi.org/10.1002/brb3.2125

Ejemplares similares

Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders
por: Motamedi, Seyedamirhosein, et al.
Publicado: (2020)

Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
por: Duan, Tianjiao, et al.
Publicado: (2018)

Disease Course and Outcomes in Patients With the Limited Form of Neuromyelitis Optica Spectrum Disorders and Negative AQP4-IgG Serology at Disease Onset: A Prospective Cohort Study
por: Chen, Xiaodong, et al.
Publicado: (2022)

CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
por: Tradtrantip, Lukmanee, et al.
Publicado: (2019)

Incidence of AQP4-IgG seropositive neuromyelitis optica spectrum disorders in the Netherlands: About one in a million
por: Daniëlle van Pelt, E, et al.
Publicado: (2016)

Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder
por: Tradtrantip, Lukmanee, et al.
Publicado: (2021)

A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG
por: Wang, Xiaojuan, et al.
Publicado: (2018)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
por: Duan, Tianjiao, et al.
Publicado: (2019)

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
por: Lu, Angelo, et al.
Publicado: (2022)

AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2021)

Paraneoplastic AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review
por: Ikeguchi, Ryotaro, et al.
Publicado: (2021)

Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study
por: Schmidt, Felix A., et al.
Publicado: (2020)

Free-water diffusion tensor imaging detects occult periependymal abnormality in the AQP4-IgG-seropositive neuromyelitis optica spectrum disorder
por: Kim, Minchul, et al.
Publicado: (2022)

Long-term Efficacy of Satralizumab in AQP4-IgG–Seropositive Neuromyelitis Optica Spectrum Disorder From SAkuraSky and SAkuraStar
por: Kleiter, Ingo, et al.
Publicado: (2022)

Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders
por: Chen, Chen, et al.
Publicado: (2020)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
por: Palace, Jacqueline, et al.
Publicado: (2019)

No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosis
por: Yang, Ting-Ting, et al.
Publicado: (2016)

MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
por: Clarke, Laura, et al.
Publicado: (2021)

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)

Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population
por: Mao, Zhifeng, et al.
Publicado: (2015)

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder
por: Li, Zhichao, et al.
Publicado: (2023)

Difference in the Source of Anti-AQP4-IgG and Anti-MOG-IgG Antibodies in CSF in Patients With Neuromyelitis Optica Spectrum Disorder
por: Akaishi, Tetsuya, et al.
Publicado: (2021)

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody–Seropositive Patients
por: Ayzenberg, Ilya, et al.
Publicado: (2021)

Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica
por: Guo, Sitong, et al.
Publicado: (2021)

AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding
por: Palazzo, Claudia, et al.
Publicado: (2019)

Gut Microbiome and Bile Acid Metabolism Induced the Activation of CXCR5+ CD4+ T Follicular Helper Cells to Participate in Neuromyelitis Optica Spectrum Disorder Recurrence
por: Cheng, Xi, et al.
Publicado: (2022)

Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
por: Qin, Chuan, et al.
Publicado: (2023)

Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study
por: Zhang, Xiayin, et al.
Publicado: (2021)

The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica
por: Verkman, Alan S., et al.
Publicado: (2018)

Magnetic resonance imaging findings in a patient with seropositive neuromyelitis optica
por: Mpateni, Siviwe S., et al.
Publicado: (2018)

Neuromyelitis optica spectrum disorders with non opticospinal manifestations as initial symptoms: a long-term observational study
por: Li, Rui, et al.
Publicado: (2021)

Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience
por: Unni, Narayanan, et al.
Publicado: (2013)

Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity
por: Pisani, Francesco, et al.
Publicado: (2013)

Pregnancy-Related Attack in Neuromyelitis Optica Spectrum Disorder With AQP4-IgG: A Single-Center Study and Meta-Analysis
por: Deng, Shuwen, et al.
Publicado: (2022)

Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats
por: Kitic, Maja, et al.
Publicado: (2013)

Investigating paraneoplastic aquaporin‐4‐IgG‐seropositive neuromyelitis optica spectrum disorder through a data‐driven approach
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Fatal anti-aquaporin-4 seropositive neuromyelitis optica spectrum disorder in tuberculosis
por: Sridhar, Siddharth, et al.
Publicado: (2014)

Response to ‘The evolving mystery of why skeletal muscle is spared in seropositive neuromyelitis optica’
por: Frigeri, Antonio, et al.
Publicado: (2018)

Double seropositive neuromyelitis optica associated with COVID-19: A case report
por: Antonescu Ghelmez, Dana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q1rgjsqv4c6hntd1fogg89fd0l